ERA - Leading European Nephrology

My ERA Join ERA

Home | Video pages | Webcast | The role of complement in glomerulonephritis: are novel therapies ready for prime time?

The role of complement in glomerulonephritis: are novel therapies ready for prime time?

Share

https://www.youtube.com/watch?v=qmUaLPtC08Y copy

Other e-seminars from IWG

SGLT2 inhibition for patients with ADPKD – closing the evidence

ERA Journal Club

Potential and pitfalls of measuring circulating anti-nephrin autoantibodies in glomerular diseases

ERA Journal Club

Cardiorenal Syndrome – Perspectives from Nephrology and Internal Medicine

YNP - Young Nephrologists’ Platform

Diet and physical exercise for sarcopenia, malnutrition, and patient outcomes in CKD5 Dialysis

Nephrology in disasters, epidemics, and wartime

ERA Neph-Manual

A patient after kidney transplantation with fractures – bone anabolic therapy in CKD

Thyroid Hormone in CKD patients with diabetes: what is known, what is new

Disease-modifying anti-nephropathic drugs (DMANDs) – A definition proposed by the IWG of ERA

ERA Journal Club

Targeting bone in CKD without biopsy – novel non-invasive treatment targets

4th JSN & YNP (ERA) Joint Meeting

YNP - Young Nephrologists’ Platform

Challenges for the management of the ADPKD patient before kidney transplantation

Urology for the nephrologist

ERA Neph-Manual